期刊文献+

餐后无症状性心肌缺血与急性冠脉综合征相关研究

Study the Correlation between Myocardial Ischemia and Acute Coronary Artery Syndrome without Symptoms Postprandial
下载PDF
导出
摘要 目的:探讨餐后无症状心肌缺血与急性冠脉综合征(ACS)发生相关性及比较,餐后无症状性心肌缺血在应用ABC(阿司匹林、倍他乐克、辛伐他汀)方案干预和不干预两组之间18个月内发展为ACS统计差异性,为ACS一级预防总结经验。方法:统计2006年12月至2009年6月在我院门诊及内科住院病人中45岁以上有冠心病高危因素(高血压、高血脂、糖尿病、吸烟、肥胖)患者182例,并排除以下之一作为入选病例:①有心梗、心绞痛、心脏手术史;②充血性心力衰竭心功能≥3级(NY-HA);③持续ST段下移;④左心肥厚、传导阻滞、心室激动、心脏起搏。将入选病例进行24h心电图检查,执行1X1X1(ST段呈水平型或下斜型下降≥0.1mv,持续时间超过1m in)标准诊断心肌缺血。筛选出有餐后无症状心肌缺血102例,无餐后心肌缺血者80例,以无餐后心肌缺血者80例做为正常对照组(A组)。再将有餐后心肌缺血病人随机分成非ABC干预组50例(B组),ABC干预组52例(C组)。以上组别病人分别在当天、第四周、第六个月、12个月、18个月进行24h心电图检查及心肌坏死标记物检测。根据心肌总缺血负荷及ST/HR比较,心肌坏死物结果,统计各组病人ACS发生概率。结果:A组与B组,B组与C组,在发展成为ACS终点事件中比较差异均有统计学意义(P≤0.01)。结论:①餐后无症状心肌缺血更容易发展为急性冠脉综合征,且冠状动脉病变部位和程度更严重。②ACS方案干预有效,且经济实用,值得进一步推广。 Objective: To research the correlation between myocardial ischemia without symptoms of postprandial and acute coronary artery syndrome (ACS) and then find out the prevention for ACS, we compared the group intervented with asprin, betaloc and simvastatin for myocardial ischemia without symptoms postprandial and that without intervention resulted in ACS during 18 months. Method: 182 cases oyer 45 years old with high fish of CHD such as hypertension, hyperlipidemia diabetes mellitus smoking and obesity were collected statistically from Dec. 2006 to Jun. 2009. While none of such symptome disease were included(1)with history of myocardial infarction, anginapectoris and surgery for heart disease ; (2)more than Ⅲ levels of congenital heart failure; (3)continousely ST decreased;(4)with left ventricular hypertrophy, conduct block, ventricular activation or cardiac pacing. All the cases were examined with 24 hours dynamic ECG, the myocardial ischemia diagnosed standard is 1X1X1. The control group (A group) was 80 cases without postprandial myocardial ischemia. Those 102 cases with postprandial without symptom myocardial ischemia were divided randomly into B group (50 cases intervented without ACB) and C group (with intervention of ABC for 52 cases) . All above cases were detected for markers of myocardial hecrosis and 24 hours dynamic ECG at that day, the fourth week, the sixth month, 12th month and 18th month respectively. The ACS occurrence rate were sumped up statistically according to the result of myocardial ischemia. Result: There's significant difference of myocardial endpoint accident resuh to ACS between A group and B group. B group and C group statistically (P≤0.01 ). Conclusion: (1)It's easy to be ACS for myocardial ischemia without symptoms of postprandial esp for the site of coronary artery.(2)It's worth to spread ACS intervention method economically.
出处 《河北医学》 CAS 2009年第11期1286-1288,共3页 Hebei Medicine
关键词 心肌缺血 急性冠脉综合征 药物干预 Myocardial ischemia Acute coronary artery syndrome Drug intervention
  • 相关文献

参考文献4

二级参考文献26

  • 1路方红,吕东玲,阮景纯,孙晓玲,吴思群.应用24小时动态心电图评价冠心病心率变异性(摘要)[J].临床心电学杂志,1994,3(4):165-165. 被引量:8
  • 2李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 3Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 4Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 5Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 6CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 7Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 8Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
  • 9Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.

共引文献2161

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部